Magdalena E Sobieszczyk

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. pmc HIV serostatus disclosure is not associated with safer sexual behavior among HIV-positive men who have sex with men (MSM) and their partners at risk for infection in Bangkok, Thailand
    Nneka Edwards-Jackson
    SEARCH, 104 Rajdumri Road, Pathumwan, Bangkok, 10330, Thailand
    AIDS Res Ther 9:38. 2012
  2. pmc Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries
    Aileen Y Chang
    Department of Vector Borne Disease, Nicaraguan Ministry of Health, Managua, Nicaragua
    Int J Health Geogr 8:49. 2009
  3. doi request reprint Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study
    Magdalena E Sobieszczyk
    Division of Infectious Diseases, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 48:272-80. 2008
  4. ncbi request reprint Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
    Magdalena E Sobieszczyk
    Department of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, 630 W 168th Street, PH 8W 876, New York, NY 10032, USA
    J Antimicrob Chemother 54:566-9. 2004
  5. ncbi request reprint Engaging members of African American and Latino communities in preventive HIV vaccine trials
    Magdalena E Sobieszczyk
    Department of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 51:194-201. 2009
  6. ncbi request reprint Advances in antiretroviral therapy
    Magdalena E Sobieszczyk
    Columbia University Medical Center, New York, NY, USA
    Top HIV Med 14:36-62. 2006
  7. pmc The challenge of HIV-1 subtype diversity
    Barbara S Taylor
    Department of Medicine and the Division of Infectious Diseases, Columbia University Medical Center, New York 10032, USA
    N Engl J Med 358:1590-602. 2008
  8. doi request reprint Translational research insights from completed HIV vaccine efficacy trials
    Hong Van Tieu
    Laboratory of Infectious Disease Prevention, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA
    J Acquir Immune Defic Syndr 63:S150-4. 2013
  9. pmc Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects
    Lindsey R Baden
    Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, MA, USA
    J Infect Dis 204:1541-9. 2011
  10. ncbi request reprint Advances in antiretroviral therapy
    Magdalena E Sobieszczyk
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Top HIV Med 13:24-44. 2005

Collaborators

Detail Information

Publications13

  1. pmc HIV serostatus disclosure is not associated with safer sexual behavior among HIV-positive men who have sex with men (MSM) and their partners at risk for infection in Bangkok, Thailand
    Nneka Edwards-Jackson
    SEARCH, 104 Rajdumri Road, Pathumwan, Bangkok, 10330, Thailand
    AIDS Res Ther 9:38. 2012
    ..abstract:..
  2. pmc Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries
    Aileen Y Chang
    Department of Vector Borne Disease, Nicaraguan Ministry of Health, Managua, Nicaragua
    Int J Health Geogr 8:49. 2009
    ..A surveillance system using Google Earth and GIS mapping technologies was developed in Nicaragua as a management tool...
  3. doi request reprint Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study
    Magdalena E Sobieszczyk
    Division of Infectious Diseases, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 48:272-80. 2008
    ..To assess the prevalence of metabolic syndrome (MetSynd) among participants of the Women's Interagency HIV Study and to describe the association of MetSynd with HIV infection, antiretroviral therapies, and sociodemographic factors...
  4. ncbi request reprint Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
    Magdalena E Sobieszczyk
    Department of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, 630 W 168th Street, PH 8W 876, New York, NY 10032, USA
    J Antimicrob Chemother 54:566-9. 2004
    ..The treatment of infections caused by multidrug-resistant (MDR) Gram-negative organisms poses a therapeutic challenge. The use of polymyxin B has been resurrected specifically for this purpose...
  5. ncbi request reprint Engaging members of African American and Latino communities in preventive HIV vaccine trials
    Magdalena E Sobieszczyk
    Department of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 51:194-201. 2009
    ..The success in engaging and enrolling AAs and Latinos in phase 1 and phase 2 vaccine trials at 2 research sites in New York City is described...
  6. ncbi request reprint Advances in antiretroviral therapy
    Magdalena E Sobieszczyk
    Columbia University Medical Center, New York, NY, USA
    Top HIV Med 14:36-62. 2006
    ....
  7. pmc The challenge of HIV-1 subtype diversity
    Barbara S Taylor
    Department of Medicine and the Division of Infectious Diseases, Columbia University Medical Center, New York 10032, USA
    N Engl J Med 358:1590-602. 2008
  8. doi request reprint Translational research insights from completed HIV vaccine efficacy trials
    Hong Van Tieu
    Laboratory of Infectious Disease Prevention, Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA
    J Acquir Immune Defic Syndr 63:S150-4. 2013
    ..The experience from the past 5 years highlights the importance of conducting efficacy studies that continue to move us closer toward the goal of a safe, effective, durable, and universal HIV preventive vaccine...
  9. pmc Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects
    Lindsey R Baden
    Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, MA, USA
    J Infect Dis 204:1541-9. 2011
    ....
  10. ncbi request reprint Advances in antiretroviral therapy
    Magdalena E Sobieszczyk
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Top HIV Med 13:24-44. 2005
    ..This review will highlight the major findings relevant to clinicians and clinical investigators...
  11. ncbi request reprint Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA
    Magdalena E Sobieszczyk
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Top HIV Med 12:9-29. 2004
    ..This reviews summarizes new information relevant to clinicians and clinical researchers...
  12. doi request reprint Host genetic polymorphisms associated with innate immune factors and HIV-1
    Magdalena E Sobieszczyk
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Curr Opin HIV AIDS 6:427-34. 2011
    ....
  13. pmc Anaemia in acute HIV-1 subtype C infection
    Koleka Mlisana
    Centre for the AIDS Programme of Research in South Africa CAPRISA, University of KwaZulu Natal, Durban, South Africa
    PLoS ONE 3:e1626. 2008
    ....